encainide has been researched along with Arrhythmia in 140 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 86 (61.43) | 18.7374 |
1990's | 53 (37.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (0.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
D'Este, D; Sorbo, MD | 1 |
Sanna, GP | 1 |
DiBianco, R; Fletcher, RD; Gottdiener, JS | 1 |
Duff, HJ; Oates, JA; Roden, DM; Woosley, RL | 1 |
Chesnie, B; Lown, B; Podrid, P; Raeder, E | 1 |
Roden, DM; Woosley, RL | 1 |
Harrison, DC; Kates, RE; Peters, F; Winkle, RA | 1 |
Derbekyan, VA; Lisbona, R; Sami, MH | 1 |
Heger, JJ; Klein, GJ; Naccarelli, GV; Prystowsky, EN; Rinkenberger, RL; Zipes, DP | 1 |
Carey, EL; Duff, HJ; Oates, JA; Primm, RK; Roden, DM; Wang, T; Wilkinson, GR; Woosley, RL | 1 |
Bleifeld, W; Kuch, B; Kuck, KH; Kunze, KP; Schlüter, M | 1 |
Abdollah, H; Brugada, P; Green, M; Wehr, M; Wellens, HJ | 1 |
Harrison, DC; Mead, RH | 1 |
Bigger, JT | 4 |
Orning, OM | 1 |
Hellestrand, KJ | 1 |
Heger, JJ; Prystowsky, EN; Zipes, DP | 3 |
Berchtold-Kanz, E; Hust, M; Just, H; Nitsche, K; Schwarz, G | 1 |
Luck, JC; Mann, DE; Pratt, CM; Wyndham, CR | 1 |
Gammans, RE; Higgins, SB; Mayol, RF; Oates, JA; Reele, SB; Roden, DM; Woosley, RL | 1 |
Graboys, TB | 1 |
Benchimol, A; Desser, KB | 1 |
Hess, D | 1 |
Harrison, DC; Kates, RE; Peters, F; Tucker, C; Winkle, RA | 1 |
Duff, HJ; Kronenberg, MW; Primm, RK; Roden, DM; Woosley, RL | 1 |
Griffin, JC; Mason, JW; Ross, D; Winkle, RA | 1 |
Harrison, DC; Kates, RE; Keefe, DL | 1 |
Heger, JJ; Jackman, WM; Naccarelli, GV; Prystowsky, EN; Rinkenberger, RL; Zipes, DP | 1 |
Byrne, JE; Gomoll, AW | 1 |
Bates, HR; Cohen, AI; DiBianco, R; Fletcher, RD; Gottdiener, JS; Katz, RJ; Sauerbrunn, B; Singh, SN | 1 |
Harrison, DC; Peters, FA; Tucker, CR; Winkle, RA | 1 |
Dawson, AK; Duff, HJ; Oates, JA; Roden, DM; Smith, RF; Woosley, RL | 1 |
Anderson, JL; Carlson, M; Davies, R; Duff, HJ; Greene, HL; Hallstrom, AP; Huther, M; Kammerling, JM; Romhilt, DW | 1 |
Gehret, JR; Kothstein, T; Lynch, JJ; Stupienski, RF; Wallace, AA | 1 |
DeMaria, A; Gottlieb, S; Greene, HL; Hallstrom, A; Huther, M; Pratt, CM; Young, JB | 1 |
Anderson, JL; Buckingham, TA; Carlson, MD; Carson, PE; Hallstrom, A; Henthorn, RW; Platia, EV | 1 |
Anderson, JL; Capone, RJ; Cohen, JD; Epstein, AE; Hallstrom, AP; Liebson, PR; Rogers, WJ; Seals, AA; Wyse, DG | 1 |
Barker, AH; Brooks, MM; Capone, R; Echt, DS; Greene, HL; Liebson, PR; Mitchell, LB; Peters, RW | 1 |
Brooks, MM; Gorkin, L; Kellen, J; Morris, M; Pawitan, Y; Schoenberger, JA; Schron, EB; Shumaker, S; Verter, J; Wiklund, I | 1 |
Brooks, MM; Friedmann, E; Goldner, F; Haakenson, C; Morris, M; Obias-Manno, D; Somelofski, C; Thomas, SA; Wimbush, F | 1 |
Josephson, ME; Krishnan, SC | 1 |
Dougherty, AH; Naccarelli, GV; Wiggins, S; Wolbrette, D | 1 |
Altemeier, WA; Roden, DM; Turgeon, J; Wikswo, JP; Wisialowski, TA; Wong, W | 1 |
Tonkin, AM | 1 |
Brunden, MN; Buchanan, LV; Gibson, JK; Kabell, G; Turcotte, UM | 1 |
Vaughan Williams, EM | 2 |
Greene, HL; Henthorn, RW; Katz, RJ; Roden, DM; Salerno, DM; Woosley, RL | 1 |
Akiyama, T; Barker, AH; Campbell, WB; Friedman, L; Josephson, RA; Keller, M; Papa, L; Pawitan, Y; Rubbert, P | 1 |
Pratt, CM | 1 |
Akhtar, M; Breithardt, G; Camm, AJ; Coumel, P; Janse, MJ; Lazzara, R; Myerburg, RJ; Schwartz, PJ; Waldo, AL; Wellens, HJ | 1 |
Katz, A; Knilans, TK; Prystowsky, EN | 1 |
Gloor, HO | 1 |
Somberg, J | 2 |
Kerin, NZ | 1 |
Arensberg, D; Baker, A; Barker, AH; Echt, DS; Friedman, L; Greene, HL; Liebson, PR; Mitchell, LB; Obias-Manno, D; Peters, RW | 1 |
Pritchett, EL; Wilkinson, WE | 1 |
Bigger, JT; Epstein, AE; Hallstrom, AP; Reynolds-Haertle, RA; Romhilt, DW; Wyse, DG | 1 |
Cohen, JD; Hallstrom, A; Mahmarian, J; McBride, R; Steinberg, JS; Wyse, DG | 1 |
Benson, DW; Fish, FA; Gillette, PC | 1 |
Garson, A; Perry, JC | 1 |
Capone, RJ; el-Sherif, N; Geraci, TS; Handshaw, K; Morganroth, J; Pawitan, Y; Schlant, RC; Waldo, AL | 1 |
Moye, LA; Pratt, CM | 1 |
Anderson, JL | 3 |
Kesselbrenner, M; Tartini, A | 1 |
Estes, NA; Manolis, AS; Weintraub, AR | 1 |
Kennedy, HL | 1 |
Eldar, M; Franz, MR; Griffin, JC; Herre, JM; Oeff, M; Scheinman, MM; Titus, C | 1 |
Cook, JR; Reiffel, JA | 1 |
Case, CL; Gillette, PC | 1 |
Moye, L; Pratt, CM | 1 |
Funck-Brentano, C; Pavlou, HN; Roden, DM; Turgeon, J; Wong, W | 1 |
Carver, J; Karalis, DG; Kutalek, SP; Michelson, EL; Nydegger, C; Pina, IL; Porter, RS | 1 |
Turakhia, DP | 1 |
Pool, PE | 2 |
Thomis, JA | 1 |
Bayés de Luna, A; Borja, J; Guindo, J; Madoery, C; Roman, M | 1 |
Gottlieb, SS; Kukin, ML; Medina, N; Packer, M; Yushak, M | 1 |
Kates, RE; Liem, LB | 1 |
Nightingale, SL | 1 |
Lown, B; Podrid, PJ; Saini, V; Slater, W | 1 |
Abi Samra, F | 1 |
Coyle, JD; Schaal, SF | 1 |
Ruskin, JN | 1 |
Maloney, JD | 1 |
Gottlieb, SS | 1 |
Marcus, FI; Podrid, PJ | 1 |
Camm, AJ; Garratt, C; Ward, DE | 1 |
Caron, JF; Dupuis, BA; Kacet, S; Kher, AR; Lekieffre, JP; Libersa, CC; Poirier, JM; Wanszelbaum, H | 1 |
Engel, T; Kelliher, GJ; Kowey, P; Wetstein, L | 1 |
Gallo, DG; Quart, BD; Sami, MH; Wood, AJ | 1 |
Durkee, J; Hsu, PH; Lee, IK; Morganroth, J; Pool, PE; Salerno, DM; Somberg, JC | 1 |
Morganroth, J; Nestico, PF | 2 |
Nattel, S; Zeng, FD | 1 |
Antonaccio, MJ; Byrne, JE; Gomoll, AW | 1 |
Antonaccio, MJ; Verjee, S | 1 |
Brugada, P; Wellens, HJ | 1 |
Sami, MH | 1 |
Roden, DM; Wilkinson, GR; Wood, AJ; Woosley, RL | 1 |
Harrison, DC; Kates, RE; Quart, BD | 1 |
Morganroth, J | 2 |
Horowitz, LN | 1 |
Lown, B; Podrid, PJ; Raeder, E; Tordjman, T | 1 |
Soyka, LF | 2 |
Garson, A; Moak, JP; Smith, RT | 1 |
Bettini, R; Disertori, M; Furlanello, F; Gramegna, L; Mosna, G; Vergara, G | 1 |
Levine, E; Somberg, JC; Tepper, D; Zanger, D | 1 |
Gomoll, AW | 1 |
Chase, SL; Sloskey, GE | 1 |
Brogden, RN; Todd, PA | 1 |
Barbey, JT; Echt, DS; Roden, DM; Thompson, KA; Woosley, RL | 1 |
Lampert, S; Lown, B; Podrid, PJ; Slater, W | 1 |
Colucci, RD | 1 |
Arlotta, C; Bongiorni, MG; Contini, C; Levorato, D; Paperini, L | 1 |
Podrid, PJ | 2 |
Carey, EL; Duff, HJ; Primm, RK; Roden, DM; Wang, T; Woosley, RL | 1 |
34 review(s) available for encainide and Arrhythmia
Article | Year |
---|---|
[When and how to treat ventricular ectopic beats].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Encainide; Exercise Test; Humans; Incidence; Prevalence; Prognosis; Propafenone; Randomized Controlled Trials as Topic; Sodium Channel Blockers; Sports; Ventricular Premature Complexes | 2010 |
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Dogs; Encainide; Hemodynamics; Humans; Myocardial Contraction; Quinidine; Verapamil | 1982 |
Therapy with investigational antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Tocainide | 1984 |
Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Coronary Disease; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Piperidines; Tachycardia; Tocainide; Ventricular Fibrillation | 1984 |
Electrophysiology and pharmacology of aprindine, encainide, and propafenone.
Topics: Action Potentials; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Electrocardiography; Encainide; Heart; Humans; Indenes; Propafenone; Propiophenones | 1984 |
Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Tocainide | 1984 |
New antiarrhythmic drugs: their place in therapy.
Topics: Action Potentials; Ajmaline; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Tosylate; Disopyramide; Encainide; Hemodynamics; Humans; Kinetics; Moricizine; Morpholines; Phenothiazines; Piperidines; Verapamil | 1981 |
Treatment of ventricular arrhythmias after CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Ventricular Function, Left | 1992 |
Classifying antiarrhythmic actions: by facts or speculation.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Heart; Humans; Imidazoles | 1992 |
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
Ventricular arrhythmias: risk stratification and approach to therapy after the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Pilot Projects; Risk Factors | 1990 |
[What is the latest in anti-arrhythmia therapy?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden, Cardiac; Encainide; Flecainide; Humans | 1991 |
Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrocardiography; Encainide; Flecainide; Humans; Propafenone | 1991 |
The Cardiac Arrhythmia Suppression Trial: background, interim results and implications.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Survival Analysis | 1990 |
Clinical implications of new studies in the treatment of benign, potentially malignant and malignant ventricular arrhythmias.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Risk Factors; Sotalol; Ventricular Fibrillation | 1990 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
Reassessment of benefit-risk ratio and treatment algorithms for antiarrhythmic drug therapy after the cardiac arrhythmia suppression trial.
Topics: Algorithms; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Evaluation; Encainide; Flecainide; Humans; Odds Ratio; Time Factors; Ventricular Fibrillation | 1990 |
Encainide--an updated safety profile.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Heart Conduction System; Heart Failure; Humans | 1990 |
Update: cardiac antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Propafenone; Propanolamines | 1989 |
The clinical use of class IC antiarrhythmic drugs.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Propafenone | 1989 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Calcium Channel Blockers; Electrophysiology; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Moricizine; Phenothiazines; Piperidines; Quaternary Ammonium Compounds; Sotalol; Tocainide | 1985 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Electrophysiology, hemodynamic and arrhythmia efficacy model studies on encainide.
Topics: Administration, Oral; Anilides; Animals; Arrhythmias, Cardiac; Biotransformation; Drug Evaluation, Preclinical; Electrocardiography; Electrophysiology; Encainide; Hemodynamics; Injections, Intravenous; Kinetics; Liver | 1986 |
Disposition kinetics of encainide and metabolites.
Topics: Anilides; Arrhythmias, Cardiac; Biological Availability; Biotransformation; Encainide; Female; Humans; Kidney Diseases; Kinetics; Liver; Liver Cirrhosis; Pregnancy | 1986 |
Treatment of supraventricular arrhythmias with encainide.
Topics: Anilides; Arrhythmias, Cardiac; Atrial Fibrillation; Electrophysiology; Encainide; Humans; Tachycardia | 1986 |
Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials.
Topics: Administration, Oral; Anilides; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Encainide; Female; Heart Ventricles; Humans; Male; Middle Aged; Quinidine; Random Allocation; Time Factors | 1986 |
Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptoms.
Topics: Administration, Oral; Anilides; Arrhythmias, Cardiac; Electric Stimulation; Electrophysiology; Encainide; Heart Ventricles; Humans; Injections, Intravenous; Tachycardia; Ventricular Fibrillation | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
Flecainide and encainide.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans | 1987 |
Encainide: a new and potent antiarrhythmic.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Encainide; Heart; Hemodynamics; Humans | 1987 |
Encainide hydrochloride and flecainide acetate: two class 1c antiarrhythmic agents.
Topics: Anilides; Arrhythmias, Cardiac; Drug Interactions; Encainide; Flecainide; Humans | 1987 |
Encainide. A review of its pharmacological properties and therapeutic efficacy.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans | 1987 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
44 trial(s) available for encainide and Arrhythmia
Article | Year |
---|---|
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Encainide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Moricizine; Morpholines; Phenothiazines; Piperidines; Tocainide; Verapamil | 1982 |
Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainide.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Electrocardiography; Encainide; Female; Humans; Male; Middle Aged; Substance Withdrawal Syndrome; Time Factors | 1983 |
Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, Drug; Electrocardiography; Encainide; Exercise Test; Female; Heart; Heart Ventricles; Humans; Male; Middle Aged; Piperidines; Tachycardia; Time Factors | 1980 |
Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmias.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Dose-Response Relationship, Drug; Electrocardiography; Encainide; Female; Humans; Kinetics; Male; Middle Aged; Placebos | 1981 |
Treatment of frequent ventricular arrhythmia with encainide: assessment using serial ambulatory electrocardiograms, intracardiac electrophysiologic studies, treadmill exercise tests, and radionuclide cineangiographic studies.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Electrocardiography; Encainide; Exercise Test; Female; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Radionuclide Imaging | 1982 |
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Failure; Humans; Moricizine; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Survival Analysis; Time Factors | 1995 |
Relations between heart failure, ejection fraction, arrhythmia suppression and mortality: analysis of the Cardiac Arrhythmia Suppression Trial.
Topics: Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Male; Middle Aged; Moricizine; Multivariate Analysis; Myocardial Infarction; Predictive Value of Tests; Prognosis; Prospective Studies; Regression Analysis; Stroke Volume; Survival Analysis | 1995 |
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Statistics as Topic; Survival Analysis | 1994 |
Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Survival Analysis; Ventricular Function, Left | 1993 |
Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Circadian Rhythm; Death, Sudden, Cardiac; Double-Blind Method; Encainide; Flecainide; Heart Arrest; Humans; Moricizine; Sympathetic Nervous System | 1994 |
Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1).
Topics: Arrhythmias, Cardiac; Chi-Square Distribution; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Prognosis; Psychological Tests; Psychology, Social; Regression Analysis; Social Support | 1993 |
Adherence and arrhythmic mortality in the cardiac arrhythmia suppression trial (CAST).
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Health Behavior; Humans; Male; Middle Aged; Patient Compliance | 1996 |
The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Survival Rate | 1992 |
Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators.
Topics: Adult; Age Factors; Aged; Aging; Arrhythmias, Cardiac; Drug Therapy, Combination; Encainide; Flecainide; Follow-Up Studies; Humans; Logistic Models; Middle Aged; Moricizine; Myocardial Infarction; Prognosis; Stroke Volume | 1992 |
Proarrhythmic potential of moricizine: strengths and limitations of a data base analysis.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Encainide; Flecainide; Humans; Information Systems; Moricizine; Phenothiazines; Tachycardia | 1990 |
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
Topics: Actuarial Analysis; Anilides; Arrhythmias, Cardiac; Electrocardiography; Encainide; Flecainide; Follow-Up Studies; Heart Arrest; Heart Failure; Humans; Morbidity; Myocardial Infarction; Patient Compliance | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction | 1991 |
Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in patients surviving open label titration but not randomized to double-blind therapy.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Regression Analysis | 1991 |
Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chi-Square Distribution; Double-Blind Method; Encainide; Female; Flecainide; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Placebos; Proportional Hazards Models; Prospective Studies; Reference Values; Risk Factors | 1991 |
The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Mass Media; Moricizine; National Institutes of Health (U.S.); Phenothiazines; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 1990 |
The Cardiac Arrhythmia Suppression Trial: background, interim results and implications.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Survival Analysis | 1990 |
Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Europe; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic; Research Design; United States; United States Food and Drug Administration | 1990 |
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Double-Blind Method; Encainide; Female; Flecainide; Humans; Male; Moricizine; Phenothiazines; Propranolol; Quinidine; Randomized Controlled Trials as Topic | 1990 |
CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Encainide; Flecainide; Humans; Moricizine; Multicenter Studies as Topic; Phenothiazines; Randomized Controlled Trials as Topic | 1990 |
Efficacy of encainide in supraventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Encainide; Humans; Tachycardia | 1990 |
Recasting the approach to the treatment of potentially malignant ventricular arrhythmias after the CAST study.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cricetinae; Encainide; Flecainide; Humans; Ventricular Function, Left | 1990 |
Clinical aspects of trial design: what can we expect from the cardiac arrhythmia suppression trial?
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Electric Stimulation; Electrocardiography; Encainide; Flecainide; Heart; Humans; Randomized Controlled Trials as Topic; Research Design; Ventricular Function | 1990 |
Encainide for cardiac arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Encainide; Heart Ventricles; Humans; Kinetics | 1987 |
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Encainide; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation | 1989 |
Encainide and flecainide: are they interchangeable?
Topics: Adolescent; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Encainide; Exercise Test; Female; Flecainide; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic | 1989 |
An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Ethics, Medical; Flecainide; Humans; Myocardial Infarction; United States; United States Food and Drug Administration | 1989 |
Consequences of the Cardiac Arrhythmia Suppression Trial: calamity or clarity?
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Consumer Product Safety; Double-Blind Method; Encainide; Flecainide; Humans; Information Services; National Institutes of Health (U.S.); Random Allocation; United States; United States Food and Drug Administration | 1989 |
The use of antiarrhythmic agents in heart failure: implications of CAST.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Heart Failure; Hemodynamics; Humans; Risk Factors | 1989 |
Lessons to be learned from the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Prognosis; Risk Factors | 1989 |
Lessons from the cardiac arrhythmia suppression trial.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Moricizine; Myocardial Infarction; Phenothiazines; United States | 1989 |
Flecainide and CAST.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Encainide; Flecainide; Humans; Multicenter Studies as Topic; Myocardial Infarction; Product Surveillance, Postmarketing; Random Allocation | 1989 |
Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Encainide; Exercise Test; Female; Humans; Male; Middle Aged; Placebos | 1985 |
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Encainide; Female; Flecainide; Heart Failure; Humans; Imipramine; Male; Middle Aged; Moricizine; Myocardial Infarction; Phenothiazines; Random Allocation; Stroke Volume | 1988 |
Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Digoxin; Double-Blind Method; Drug Interactions; Electrocardiography; Encainide; Female; Humans; Male; Middle Aged; Quinidine; Random Allocation | 1986 |
Dosing recommendations for encainide.
Topics: Anilides; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Encainide; Heart Ventricles; Humans; Kinetics; Random Allocation | 1986 |
Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials.
Topics: Administration, Oral; Anilides; Arrhythmias, Cardiac; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Encainide; Female; Heart Ventricles; Humans; Male; Middle Aged; Quinidine; Random Allocation; Time Factors | 1986 |
Safety and efficacy of encainide for malignant ventricular arrhythmias.
Topics: Adult; Aged; Anilides; Arrhythmias, Cardiac; Clinical Trials as Topic; Electrophysiology; Encainide; Female; Headache; Heart Ventricles; Humans; Male; Middle Aged; Nausea; Stroke Volume; Tachycardia; Time Factors; Ventricular Fibrillation; Vomiting | 1986 |
Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Humans; Male; Middle Aged | 1988 |
66 other study(ies) available for encainide and Arrhythmia
Article | Year |
---|---|
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
Encainide for refractory ventricular tachyarrhythmia.
Topics: Adult; Aged; Ambulatory Care; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Electrophysiology; Encainide; Exercise Test; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Nausea; Risk; Tachycardia; Ventricular Fibrillation; Vomiting | 1983 |
Importance of metabolites in antiarrhythmic therapy.
Topics: Acecainide; Agranulocytosis; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Procainamide; Propranolol; Quinidine | 1983 |
Hemodynamic effects of encainide in patients with ventricular arrhythmia and poor ventricular function.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Digoxin; Electrocardiography; Encainide; Erythrocytes; Heart; Heart Rate; Hemodynamics; Humans; Middle Aged; Radionuclide Imaging; Stroke Volume; Technetium | 1983 |
Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrocardiography; Encainide; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Wolff-Parkinson-White Syndrome | 1984 |
Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.
Topics: Aged; Anilides; Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Heart; Heart Ventricles; Humans; Kinetics; Male; Middle Aged; Regression Analysis | 1984 |
Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
Topics: Administration, Oral; Adult; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Cardiac Pacing, Artificial; Electrocardiography; Encainide; Female; Heart Conduction System; Humans; Infusions, Parenteral; Male; Middle Aged; Wolff-Parkinson-White Syndrome | 1984 |
Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
Topics: Administration, Oral; Adult; Anilides; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular Node; Electrocardiography; Encainide; Female; Heart Atria; Heart Conduction System; Heart Ventricles; Humans; Infusions, Parenteral; Male; Middle Aged; Tachycardia; Wolff-Parkinson-White Syndrome | 1984 |
Identification of patients at high risk for sudden cardiac death.
Topics: Anilides; Arrhythmias, Cardiac; Death, Sudden; Encainide; Heart; Heart Ventricles; Humans; Prognosis; Sotalol; Syncope; Timolol | 1984 |
The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular Node; Benzeneacetamides; Encainide; Flecainide; Heart Atria; Humans; Lidocaine; Piperidines; Tachycardia; Tocainide; Wolff-Parkinson-White Syndrome | 1984 |
Increased incidence of side effects after encainide: a newly developed antiarrhythmic drug.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Encainide; Female; Humans; Male; Mexiletine; Middle Aged | 1984 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availability; Encainide; Half-Life; Humans; Imidazoles; Intestinal Absorption; Kinetics; Lidocaine; Metabolic Clearance Rate; Mexiletine; Propafenone; Propiophenones; Protein Binding; Tachycardia; Tocainide | 1983 |
Suppression of ventricular arrhythmias by encainide.
Topics: Anilides; Arrhythmias, Cardiac; Encainide; Heart Ventricles; Humans | 1980 |
New drugs for treating cardiac arrhythmias.
Topics: Acebutolol; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Heart Ventricles; Humans; Mexiletine; Moricizine; Morpholines; Phenothiazines; Tocainide; Verapamil | 1981 |
Newer antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Tocainide; Verapamil | 1981 |
Control of ventricular preexcitation and associated arrhythmias by encainide.
Topics: Anilides; Arrhythmias, Cardiac; Atrial Fibrillation; Electrocardiography; Encainide; Female; Heart Ventricles; Humans; Lidocaine; Middle Aged; Procainamide; Quinidine; Tachycardia; Time Factors | 1981 |
Malignant ventricular tachyarrhythmias associated with the use of encainide.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Electrocardiography; Encainide; Female; Heart Ventricles; Humans; Male; Middle Aged; Risk; Tachycardia; Time Factors; Ventricular Fibrillation | 1981 |
Electrophysiologic testing of antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Vessels; Dogs; Electrophysiology; Encainide; Heart; Time Factors; Verapamil | 1982 |
Electrophysiology of oral encainide.
Topics: Administration, Oral; Adolescent; Adult; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Electrophysiology; Encainide; Female; Heart Conduction System; Humans; Male; Middle Aged; Purkinje Fibers | 1982 |
The antiarrhythmic action of encainide versus ventricular arrhythmias in the conscious dog following coronary artery ligation.
Topics: Administration, Oral; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Dogs; Electrocardiography; Encainide; Female; Heart Rate; Injections, Intravenous; Ligation; Male; Time Factors | 1982 |
Acute hemodynamic effects of intravenous encainide in patients with heart disease.
Topics: Adult; Aged; Angiocardiography; Anilides; Arrhythmias, Cardiac; Blood Pressure; Cardiac Catheterization; Cardiac Output; Encainide; Female; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Stroke Volume; Time Factors; Vascular Resistance | 1982 |
Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequency.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Electrophysiology; Encainide; Exercise Test; Heart Conduction System; Humans; Middle Aged; Monitoring, Physiologic; Myocardial Contraction; Placebos; Random Allocation; Time Factors | 1982 |
Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disease Models, Animal; Dogs; Electric Stimulation; Electrophysiology; Encainide; Female; Heart Ventricles; Injections, Intravenous; Male; Myocardial Infarction | 1993 |
ST segment elevation induced by class IC antiarrhythmic agents: underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Electrocardiography; Electrophysiology; Encainide; Flecainide; Humans; Male; Middle Aged; Sodium Channel Blockers; Ventricular Fibrillation | 1998 |
A critical appraisal of the cardiac arrhythmia suppression trial (CAST).
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Encainide; Flecainide; Humans; Imipramine; Moricizine; Multicenter Studies as Topic; Pilot Projects; Randomized Controlled Trials as Topic; Risk Factors | 1991 |
Suppression of longitudinal versus transverse conduction by sodium channel block. Effects of sodium bolus.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Encainide; Female; Heart Conduction System; Male; Sodium Channels; Sodium Chloride | 1992 |
Effects of ibutilide on spontaneous and induced ventricular arrhythmias in 24-hour canine myocardial infarction: a comparative study with sotalol and encainide.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electrocardiography; Encainide; Hemodynamics; Myocardial Infarction; Sotalol; Sulfonamides | 1992 |
The spectrum of CAST I and II.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Death, Sudden, Cardiac; Encainide; Flecainide; Humans; Moricizine; Randomized Controlled Trials as Topic | 1991 |
Crime, misdemeanor, and arrhythmia decoding CAST.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Encainide; Flecainide; Heart Ventricles; Humans; Moricizine; Myocardial Infarction; Randomized Controlled Trials as Topic; Research Design; Risk Factors | 1991 |
Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; North Carolina; Survival Rate; Tachycardia, Supraventricular; United States | 1991 |
Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Death, Sudden; Encainide; Flecainide; Heart Arrest; Humans; Incidence; Retrospective Studies; Risk Factors; Tachycardia; Tachycardia, Supraventricular | 1991 |
Encainide and flecainide in children: separating the wheat from the chaff.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Encainide; Flecainide; Humans; Risk Factors | 1991 |
The management of cardiac arrhythmias: The role of encainide and sotalol. A symposium. March 24-25, 1988. Proceedings.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Sotalol | 1990 |
Encainide-induced encephalopathy in a patient with chronic renal failure.
Topics: Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Female; Humans; Kidney Failure, Chronic; Substance-Related Disorders | 1990 |
Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
Topics: Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Electrophysiology; Encainide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence | 1990 |
Late proarrhythmia and understanding the time of occurrence of proarrhythmia.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans | 1990 |
Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiology; Encainide; Flecainide; Follow-Up Studies; Humans; Middle Aged; Tachycardia; Time Factors; Ventricular Fibrillation | 1990 |
Physician attitudes toward the use of type IC antiarrhythmics after the Cardiac Arrhythmia Suppression Trial (CAST).
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Attitude of Health Personnel; Drug Utilization; Encainide; Flecainide; Humans; Physicians; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Surveys and Questionnaires; United States; United States Food and Drug Administration | 1990 |
Treatment of ventricular arrhythmias in children without structural heart disease with class IC agents as guided by invasive electrophysiology.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Child; Electrophysiology; Encainide; Female; Flecainide; Humans; Male; Tachycardia | 1990 |
The cardiac arrhythmia suppression trial: implications for antiarrhythmic drug development.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Evaluation; Encainide; Flecainide; Humans; Pilot Projects; Time Factors | 1990 |
Genetically determined steady-state interaction between encainide and quinidine in patients with arrhythmias.
Topics: Aged; Anilides; Arrhythmias, Cardiac; Dealkylation; Drug Interactions; Electrocardiography; Encainide; Female; Genetics; Humans; Male; Middle Aged; Phenotype; Quinidine | 1990 |
Effects of encainide and metabolizer phenotype on ventricular conduction during exercise.
Topics: Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography, Ambulatory; Encainide; Female; Heart Conduction System; Humans; Male; Microcomputers; Middle Aged; Phenotype; Physical Exertion | 1990 |
Antiarrhythmic therapy--conventional wisdom challenged.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans | 1990 |
Adverse hemodynamic and clinical effects of encainide in severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dyspnea; Encainide; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume | 1989 |
Drugs for cardiac arrhythmias: new warning.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Humans | 1989 |
From the Food and Drug Administration.
Topics: Allergens; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Child; Drug Prescriptions; Encainide; Flecainide; Humans; Mortality; Patient Compliance | 1989 |
The cardiac arrhythmia suppression trial (CAST).
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Encainide; Flecainide; Humans; Myocardial Infarction; Pilot Projects | 1989 |
The cardiac arrhythmia suppression trial.
Topics: Aged; Anilides; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Male | 1989 |
Drug interaction studies and encainide use in renal and hepatic impairment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anilides; Anti-Arrhythmia Agents; Anticoagulants; Antipsychotic Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Cimetidine; Digoxin; Diuretics; Drug Interactions; Encainide; Humans; Hypoglycemic Agents; Kidney Diseases; Liver Diseases; Middle Aged; Prospective Studies; Protein Binding; Retrospective Studies | 1986 |
[Rational treatment of heart rhythm disorders. International symposium on "The Management of Cardiac Arrhythmias: the Role of Encainide and Sotalol". 24-25 March 1988, Wallingford (USA)].
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Sotalol | 1988 |
Effects of encainide on the inducibility of ventricular arrhythmia in normal anesthetized dogs.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electric Stimulation; Encainide; Female; Heart Ventricles; Male; Tachycardia; Ventricular Fibrillation | 1986 |
A symposium: Encainide. January 24-25, 1986, Phoenix, Arizona.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans | 1986 |
Electrophysiology in assessing supraventricular arrhythmias: value of programmed stimulation in predicting and understanding efficacy of encainide.
Topics: Administration, Oral; Adult; Anilides; Arrhythmias, Cardiac; Electric Stimulation; Electrocardiography; Electrophysiology; Encainide; Female; Heart; Heart Atria; Heart Ventricles; Humans; Injections, Intravenous; Male; Middle Aged; Tachycardia; Vagus Nerve | 1986 |
Acute intravenous and long-term oral hemodynamic effects of encainide.
Topics: Administration, Oral; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Encainide; Female; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Stroke Volume; Time Factors | 1986 |
Relation of blood level and metabolites to the antiarrhythmic effectiveness of encainide.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Biotransformation; Circadian Rhythm; Dose-Response Relationship, Drug; Encainide; Heart Ventricles; Humans; Kinetics; Myocardial Contraction; Time Factors | 1986 |
Safety of encainide for the treatment of ventricular arrhythmias.
Topics: Aged; Anilides; Arrhythmias, Cardiac; Electrocardiography; Encainide; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Middle Aged; Retrospective Studies | 1986 |
Newer antiarrhythmic drugs in children.
Topics: Adolescent; Adult; Amiodarone; Anilides; Arrhythmias, Cardiac; Child; Child, Preschool; Electrocardiography; Encainide; Humans; Infant; Mexiletine; Moricizine; Phenothiazines; Propafenone | 1987 |
Risk factors for the development of proarrhythmic events.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Flecainide; Hospitalization; Humans; Information Systems; Risk; Tachycardia | 1987 |
Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model.
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electrocardiography; Encainide; Female; Flecainide; Male; Myocardial Infarction; Sotalol | 1987 |
Clinical predictors of arrhythmia worsening by antiarrhythmic drugs.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Encainide; Female; Heart Ventricles; Humans; Male; Mexiletine; Middle Aged; Quinidine; Retrospective Studies | 1988 |
Encainide.
Topics: Anilides; Arrhythmias, Cardiac; Encainide; Humans | 1988 |
Long-term efficacy of oral encainide in frequent and repetitive ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chronic Disease; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Encainide; Exercise Test; Female; Follow-Up Studies; Heart Ventricles; Humans; Male; Middle Aged; Monitoring, Physiologic; Tachycardia | 1988 |
Safety considerations and dosing guidelines for encainide in supraventricular arrhythmias.
Topics: Adult; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Administration Schedule; Encainide; Female; Hemodynamics; Humans; Male; Middle Aged; Tachycardia, Supraventricular | 1988 |
Aggravation of ventricular arrhythmia. A drug-induced complication.
Topics: Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Drug Evaluation; Electrocardiography; Encainide; Flecainide; Humans; Mexiletine; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine | 1985 |
Spectrum of antiarrhythmic response to encainide.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Drug Evaluation; Electrocardiography; Encainide; Female; Heart Ventricles; Humans; Male; Middle Aged | 1985 |